Y Mabs Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $345k | 21k | 16.31 |
| 2023-12-31 | $133k | 20k | 6.82 |
| 2023-09-30 | $100k | 18k | 5.47 |
| 2023-06-30 | $125k | 18k | 6.84 |
| 2023-03-31 | $124k | 25k | 5.02 |
| 2022-12-31 | $86k | 18k | 4.88 |
| 2022-03-31 | $168k | 14k | 11.86 |
| 2019-09-30 | $22M | 838k | 26.06 |
| 2019-06-30 | $17M | 748k | 22.87 |
| 2019-03-31 | $17M | 640k | 26.21 |
| 2018-12-31 | $7.9M | 390k | 20.34 |
| 2018-09-30 | $10M | 389k | 26.56 |